Cost-effectiveness of enhanced syphilis screening among HIV-positive men who have sex with men: A microsimulation model

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Tuite, Ashleigh R ^a,b   Burchell, Ann N ^b,c   Fisman, David N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ONTARIO HIV TREATMENT NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA SYNTHESIS; DISEASE SPECIFIC SURVIVAL; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL HISTORY; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; MONTE CARLO METHOD; PATIENT ATTITUDE; QUALITY OF LIFE; SCREENING TEST; SYPHILIS; BIOLOGICAL MODEL; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUALITY; MASS SCREENING; MIDDLE AGED;

ADULT; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, BIOLOGICAL; MONTE CARLO METHOD; SYPHILIS;

EID: 84903700617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101240     Document Type: Article

References (70)

1. Fenton KA, Breban R, Vardavas R, Okano JT, Martin T, et al. (2008) Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis 8: 244-253. (Pubitemid 351391990)
2. Aral SO, Fenton KA, Holmes KK (2007) Sexually transmitted diseases in the USA: temporal trends. Sex Transm Infect 83.
3. Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, et al. (2009) Reemergence of the HIV Epidemic Among Men Who Have Sex With Men in North America, Western Europe, and Australia, 1996-2005. Ann Epidemiol 19: 423-431.
4. Toronto Public Health Communicable diseases in Toronto 2012: Sexually transmitted and bloodborne diseases. Available: http://www1.toronto.ca/ staticfiles/City Of Toronto/Toronto Public Health/Communicable DiseaseControl/Communicable Disease Surveillance/Annual Reports/Files/pdf/2/1- Sexually transmitted infections-COMPLETE3.pdf. Accessed 2014 Jan 13.
5. Burchell AN, Moravan V, Allen V, Bayoumi AM, Collins E, et al. (2012) Extremely high risk of syphilis co-infection and re-diagnosis among men who have sex with men living with HIV in Ontario. 21st Annual Canadian Conference on HIV/AIDS Research. Toronto, Canada.
6. Lukehart SA (2006) Syphilis. Sexually transmitted diseases: 311-330.
7. Singh A, Romanowski B (1999) Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 12: 187-209. (Pubitemid 29196850)
8. Garnett GP, Aral SO, Hoyle DV, Cates W, Anderson RM (1997) The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis 24: 185-200.
9. Public Health Agency of Canada (2010) Canadian guidelines on sexually transmitted infections. Available: http://www.phac-aspc.gc.ca/std-mts/sti-its/ guide-lignesdir-eng.php. Accessed 2012 Nov 20.
10. Burchell AN, Allen VG, Moravan V, Gardner S, Raboud J, et al. (2013) Patterns of syphilis testing in a large cohort of HIV patients in Ontario, Canada, 2000-2009. BMC Infect Dis 13: 246.
11. Gray RT, Hoare A, Prestage GP, Donovan B, Kaldor JM, et al. (2010) Frequent testing of highly sexually active gay men is required to control syphilis. Sex Transm Dis 37: 298-305.
12. Bissessor M, Fairley CK, De Guingand D, Bradshaw CS, Chen MY (2009) Delay in the diagnosis of early syphilis among men who have sex with men: need for greater community and health provider education. Int J STD AIDS 20: 52-53.
13. Fenton KA, Nicoll A, Kinghorn G (2001) Resurgence of syphilis in England: time for more radical and nationally coordinated approaches. Sex Transm Infect 77: 309-310. (Pubitemid 32964258)
14. Bissessor M, Fairley CK, Leslie D, Howley K, Chen MY (2010) Frequent screening for syphilis as part of HIV monitoring increases the detection of early asymptomatic syphilis among HIV-positive homosexual men. J Acquir Immune Defic Syndr 55: 211-216.
15. Sena AC, White BL, Sparling PF (2010) Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis 51: 700-708.
16. Larsen SA (1998) A manual of tests for syphilis. Washington, DC: American Public Health Association.
17. Owusu-Edusei K Jr, Koski KA, Ballard RC (2011) The tale of two serologic tests to screen for syphilis-treponemal and nontreponemal: does the order matter? Sex Transm Dis 38: 448-456.
18. Owusu-Edusei K Jr, Peterman TA, Ballard RC (2011) Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithms. Sex Transm Dis 38: 1-7.
19. Goswami ND, Stout JE, Miller WC, Hecker EJ, Cox GM, et al. (2013) The footprint of old syphilis: using a reverse screening algorithm for syphilis testing in a US geographic information systems-based community outreach program. Sex Transm Dis 40: 839-841.
20. Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, et al. (2012) State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making 32: 690-700.
21. Rourke SB, Gardner S, Burchell AN, Raboud J, Rueda S, et al. (2013) Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS). Int J Epidemiol 42: 402-411.
22. Centers for Disease Control and Prevention (2007) Symptomatic early neurosyphilis among HIV-positive men who have sex with men-four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 56: 625-628.
23. Beck JR, Kassirer JP, Pauker SG (1982) A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med 73: 883-888. (Pubitemid 13211834)
24. Statistics Canada (2006) Complete life table, Canada, 2000 to 2002, Table 2a - males. Available: http://www.statcan.gc.ca/pub/84-537-x/4064441-eng.htm. Accessed 2012 Nov 20.
25. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, et al. (2008) Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 300: 51-59. (Pubitemid 351920404)
26. Shafer JK, Usilton LJ, Gleeson GA (1954) Untreated syphilis in the male Negro; a prospective study of the effect on life expectancy. Public Health Rep 69: 684-690.
27. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, et al. (2008) Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 22: 1145-1151.
28. Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, et al. (2004) Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 189: 369-376. (Pubitemid 38210572)
29. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available: http://aidsinfo.nih. gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf. Accessed 2014 Mar 11.
30. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, et al. (2005) Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 352: 570-585. (Pubitemid 40204670)
31. Kwong JC, Ratnasingham S, Campitelli MA, Daneman N, Deeks SL, et al. (2012) The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One 7: e44103.
32. World Health Organization (2008) The global burden of disease: 2004 update. Available: http://www.who.int/healthinfo/global-burden-disease/2004- report-update/en/index.html. Accessed 2012 Nov 20.
33. Pepper PV, Owens DK (2002) Cost-effectiveness of the pneumococcal vaccine in healthy younger adults. Med Decis Making 22: S45-57.
34. Grap MJ, Munro CL, Unoki T, Hamilton VA, Ward KR (2012) Ventilator-associated pneumonia: the potential critical role of emergency medicine in prevention. J Emerg Med 42: 353-362.
35. Ontario Ministry of Health and Long-Term Care Ontario Health Insurance Schedule of Benefits and Fees: Schedule of Benefits for Physician Services. Available: http://www.health.gov.on.ca/english/providers/program/ohip/sob/ physserv/physserv-mn.html. Accessed 2014 Mar 11.
36. Ontario Ministry of Health and Long-Term Care Ontario Health Insurance Schedule of Benefits and Fees: Scehdule of Benefits for Laboratory Services. Available: http://www.health.gov.on.ca/english/providers/program/ohip/sob/lab/ lab-mn.html. Accessed 2014 Mar 11.
37. Statistics Canada The Consumer Price Index. Catalogue no.62-001-XWE.
38. Owusu-Edusei K Jr, Chesson HW, Gift TL, Tao G, Mahajan R, et al. (2013) The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis 40: 197-201.
39. Canadian Agency for Drugs and Technologies in Health (2006) Guidelines for the economic evaluation of health technologies: Canada. Available: http://www.cadth.ca/media/pdf/186-EconomicGuidelines-e.pdf. Accessed 2012 Nov 20.
40. Remis RS, Swantee C, Liu J (2010) Report on HIV/AIDS in Ontario 2008. Available: http://www.ohemu.utoronto.ca/tech reports.html. Accessed 2014 Mar 11.
41. Briggs A (2005) Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value Health 8: 1-2.
42. World Health Organization Choosing interventions that are cost effective (WHO-CHOICE): Cost-effectiveness thresholds. Available: http://www.who.int/ choice/costs/CER-thresholds/en/. Accessed 2014 Mar 11.
43. Tuite AR, Fisman DN, Mishra S (2013) Screen more or screen more often? Using mathematical models to inform syphilis control strategies. BMC Public Health 13: 606.
44. Golden MR, Marra CM, Holmes KK (2003) Update on syphilis: resurgence of an old problem. JAMA 290: 1510-1514. (Pubitemid 37430408)
45. Pathela P, Braunstein SL, Schillinger JA, Shepard C, Sweeney M, et al. (2011) Men who have sex with men have a 140-fold higher risk for newly diagnosed HIV and syphilis compared with heterosexual men in New York City. J Acquir Immune Defic Syndr 58: 408-416.
46. Torrone EA, Bertolli J, Li J, Sweeney P, Jeffries WLt, et al. (2011) Increased HIV and primary and secondary syphilis diagnoses among young men-United States, 2004-2008. J Acquir Immune Defic Syndr 58: 328-335.
47. Heffelfinger JD, Swint EB, Berman SM, Weinstock HS (2007) Trends in primary and secondary syphilis among men who have sex with men in the United States. Am J Public Health 97: 1076-1083. (Pubitemid 351181931)
48. Mishra S, Boily MC, Ng V, Gold WL, Okura T, et al. (2011) The laboratory impact of changing syphilis screening from the rapid-plasma reagin to a treponemal enzyme immunoassay: a case-study from the Greater Toronto Area. Sex Transm Dis 38: 190-196.
49. Muldoon E, Mulcahy F (2011) Syphilis resurgence in Dublin, Ireland. Int J STD AIDS 22: 493-497.
50. Marcus U, Schmidt AJ, Kollan C, Hamouda O (2009) The denominator problem: estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys. BMC Public Health 9: 181.
51. Leber A, MacPherson P, Lee BC (2008) Epidemiology of infectious syphilis in Ottawa. Recurring themes revisited. Can J Public Health 99: 401-405.
52. Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, et al. (2012) Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5. Med Decis Making 32: 712-721.
53. Fleming D (1999) From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV. Sex Transm Infect 75: 2-17.
54. Ballini A, Cantore S, Fatone L, Montenegro V, De Vito D, et al. (2012) Transmission of nonviral sexually transmitted infections and oral sex. J Sex Med 9: 372-384.
55. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, et al. (1997) A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 337: 307-314. (Pubitemid 27318992)
56. Blandford JM, Gift TL, Vasaikar S, Mwesigwa-Kayongo D, Dlali P, et al. (2007) Cost-effectiveness of on-site antenatal screening to prevent congenital syphilis in rural eastern Cape Province, Republic of South Africa. Sex Transm Dis 34: S61-66. (Pubitemid 47012322)
57. Turnbull DK, Shepherd DB (2003) Post-dural puncture headache: pathogenesis, prevention and treatment. Br J Anaesth 91: 718-729. (Pubitemid 37369534)
58. Kourbatova EV, Akovbyan VA, Chesson HW, Lytkina IN, Dmitriev GA, et al. (2008) Assessment of the routine, occupation-based gonorrhea and syphilis screening program in Moscow, Russia: an analysis of sexually transmitted infection prevalence and cost-effectiveness. Sex Transm Dis 35: 453-460. (Pubitemid 351670558)
59. Blandford JM, Gift TL (2003) The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilis. Sex Transm Dis 30: 502-508. (Pubitemid 36667030)
60. Blank LJ, Rompalo AM, Erbelding EJ, Zenilman JM, Ghanem KG (2011) Treatment of syphilis in HIV-infected subjects: a systematic review of the literature. Sex Transm Infect 87: 9-16.
61. Riedner G, Rusizoka M, Todd J, Maboko L, Hoelscher M, et al. (2005) Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 353: 1236-1244. (Pubitemid 41345945)
62. Tsevat J, Durand-Zaleski I, Pauker SG (1989) Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. Am J Public Health 79: 739-743. (Pubitemid 19142914)
63. Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, et al. (1999) HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS 13: F35-43. (Pubitemid 29286695)
64. Mocroft A, Gill MJ, Davidson W, Phillips AN (1998) Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor. AIDS 12: 2161-2167. (Pubitemid 28495270)
65. Rhone SA, Hogg RS, Yip B, Sherlock C, Conway B, et al. (1998) The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study. AIDS 12: 619-624. (Pubitemid 28162101)
66. Drusano GL, Stein DS (1998) Mathematical modeling of the interrelationship of CD4 lymphocyte count and viral load changes induced by the protease inhibitor indinavir. Antimicrob Agents Chemother 42: 358-361. (Pubitemid 28114445)
67. Cook J, Dasbach E, Coplan P, Markson L, Yin D, et al. (1999) Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial. AIDS Res Hum Retroviruses 15: 499-508. (Pubitemid 29177846)
68. Fisman DN, Chan CH, Lowcock E, Naus M, Lee V (2012) Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation. Vaccine 30: 7601-7607.
69. Ward MJ, Bonomo JB, Adeoye O, Raja AS, Pines JM (2012) Cost-effectiveness of diagnostic strategies for evaluation of suspected subarachnoid hemorrhage in the emergency department. Acad Emerg Med 19: 1134-1144.
70. Jackman JD Jr, Radolf JD (1989) Cardiovascular syphilis. Am J Med 87: 425-433.